[HTML] frontiersin.org

[HTML][HTML] Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study

HL DuPont, J Suescun, ZD Jiang, EL Brown… - Frontiers in …, 2023 - frontiersin.org
Background and purpose The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …
被引用次数：38 相关文章
[HTML] nih.gov

[HTML][HTML] Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study

HL DuPont, J Suescun, ZD Jiang, EL Brown… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background and purpose The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study

H DuPont, J Suescun, Z Jiang, E Brown… - Frontiers in …, 2023 - europepmc.org
Background and purpose The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

[引用][C] Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study

HL DuPont, J Suescun, ZD Jiang, EL Brown… - … in Neurology (Web), 2023 - jglobal.jst.go.jp
Fecal microbiota transplantation in Parkinson’s disease-A randomized repeat-dose, placebo-controlled
clinical pilot study | Article Information | J-GLOBAL Art J-GLOBAL ID:202302259203663504 …

Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study

HL DuPont, J Suescun, ZD Jiang… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background and purpose The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study.

HL DuPont, J Suescun, ZD Jiang, EL Brown… - 2023 - digitalcommons.library.tmc.edu
BACKGROUND AND PURPOSE: The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study

HL DuPont, J Suescun, ZD Jiang… - Frontiers in …, 2023 - utsouthwestern.elsevierpure.com
Background and purpose: The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study.

HL DuPont, J Suescun, ZD Jiang, EL Brown… - Frontiers in …, 2023 - europepmc.org
Background and purpose The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study

HL DuPont, J Suescun, ZD Jiang, EL Brown… - 2023 - digitalcommons.library.tmc.edu
BACKGROUND AND PURPOSE: The intestinal microbiome plays a primary role in the
pathogenesis of neurodegenerative disorders and may provide an opportunity for disease …

[引用][C] Fecal Microbiota Transplantation in Parkinson's Disease-a Randomized Repeat-Dose, Placebo-Controlled Clinical Pilot Study

HL DuPont, JS Suescun, ZD Jiang, E Brown… - CPRD-D-21-00112